
Pio G 30mg Tablet
Marketer
Indi Pharma
Salt Composition
Pioglitazone (30mg)
Overview Pio G 30mg Tablet
Glypio 30mg tablets are prescribed for adult patients with type 2 diabetes to manage blood glucose levels. This helps mitigate serious diabetic complications such as vision impairment and renal dysfunction. Glypio 30mg may be administered alone or in conjunction with other medications, with or without food. Consistent daily dosing at the same time maximizes efficacy. Dosage adjustments are determined by your physician based on treatment response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate blood glucose, risking vision loss, neuropathy, nephropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Commonly reported side effects include headache, sinusitis, myalgia, and pharyngitis. Persistent or bothersome side effects warrant consultation with your doctor. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease, thyroid disorders, or specific hormonal imbalances should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Pio G 30mg Tablet
Managing Type 2 Diabetes
Major Benefits of Pio G 30mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 30mg Pio G Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Pio G 30mg Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Pio G 30mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Pio G 30mg Tablets can be ingested with or without food, however, consistent daily timing is recommended.
How Pio G 30mg Tablet works:
Glypin 30mg tablets are used to manage diabetes. Their mechanism of action involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Pio G 30mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Pio G 30mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCAUTION
The use of Pio G 30mg tablets during breastfeeding requires careful consideration. Breastfeeding should be temporarily discontinued until the mother's treatment concludes and the medication is fully cleared from her system. Close monitoring of the infant's blood glucose levels is necessary while the mother is taking Pio G 30mg tablets.
DrivingSAFE
Driving ability is typically unaffected by Pio G 30mg Tablets.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Pio G 30mg Tablet is considered safe and requires no dosage modification.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Pio G 30mg tablets, as dose modification may be necessary. Consult a physician for guidance. Pio G 30mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Pio G 30mg Tablet :
Omit any missed Pio G 30mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Pio G 30mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | PPARγ agonist (thiazolidinedione) |
